| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |